The mitral valve is an integral component of the cardiovascular system, situated within the heart to regulate blood flow. Nestled between the left atrium and left ventricle, this valve, characterized by its bicuspid structure, orchestrates the rhythmic passage of oxygenated blood during the cardiac cycle. Its two leaflets collaborate in a harmonious dance, opening and closing precisely to facilitate the unidirectional movement of blood. Ensuring the seamless flow of blood is vital for the heart's overall efficiency, and any deviation from normal mitral valve function can have profound implications. Conditions like mitral valve prolapse or stenosis, which affect the proper operation of this valve, may compromise the cardiovascular system's performance. Monitoring the health of the mitral valve is a critical aspect of comprehensive cardiovascular assessments conducted by healthcare professionals. In cases where issues with the mitral valve arise, the spectrum of treatment options varies. Healthcare providers may employ a range of interventions, from medications designed to regulate blood flow and alleviate symptoms to surgical procedures aimed at restoring optimal valve function. The choice of treatment depends on the specific nature and severity of the mitral valve condition.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States